Insider Activity of BERNS PAUL L
According to the SEC Form 4 filings, BERNS PAUL L, being in a position of
- See Remarks at Neumora Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 9819 shares for $34,459,over all time since 2025-02-18, has bought 0 shares, and sold 23690 shares for $57,927.
Biography of BERNS PAUL L
No biography is available at this moment.